Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFH1S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,169
Award facts
- Contract value 100% obligated
- $11,168.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,168.90 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen auto-injectors on December 1, 2025, with completion targeted for December 2, 2025. The award employs firm fixed price pricing and carries no set-aside designation, indicating competitive selection. The pharmaceutical product will be delivered to AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, leverages its prime IDC with the DLA to fulfill federal medical procurement needs across military and veteran healthcare systems. The SPE2DX contract encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current award for Trulicity—a diabetes treatment medication—exemplifies the company's role as a critical vendor in the federal medical supply chain and reflects its demonstrated capability to meet competitive federal procurement requirements across diverse medical product categories and transaction values.
Quick answers
Who was awarded contract SPE2DR26FFH1S?
SPE2DR26FFH1S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FFH1S worth?
The government has obligated $11,169 on SPE2DR26FFH1S.
Is contract SPE2DR26FFH1S an order under another contract?
Yes. SPE2DR26FFH1S is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFH1S competed?
The extent of competition for SPE2DR26FFH1S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award